Paul W. Hoelscher's Net Worth
$50.8 Million
Who is Paul W. Hoelscher?
Paul W. Hoelscher has an estimated net worth of $50.8 Million. This is based on reported shares across multiple companies, which include HORIZON PHARMA, INC., Reneo Pharmaceuticals, Inc., and Sagimet Biosciences Inc..
SEC CIK
Paul W. Hoelscher's CIK is 0001611468
Past Insider Trading and Trends
2021 was Paul W. Hoelscher's most active year for acquiring shares with 10 total transactions. Paul W. Hoelscher's most active month to acquire stocks was the month of December. 2022 was Paul W. Hoelscher's most active year for disposing of shares, totalling 17 transactions. Paul W. Hoelscher's most active month to dispose stocks was the month of December. 2022 saw Paul W. Hoelscher paying a total of $6,103,813.80 for 462,078 shares, this is the most they've acquired in one year. In 2022 Paul W. Hoelscher cashed out on 774,985 shares for a total of $37,666,916.68, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Horizon Therapeutics Public Ltd Co No price found
EVP, CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$68.43 | -$4,628,449.02 | 1.05K |
Scheduled
|
Apr 20
| ||
Form 4
| -57.52% | -91.71K |
$65.64 | -$29,197,396.88 | 67.72K |
Scheduled
|
Apr 6
| ||
Form 4
| -5.63% | -13.84K |
$62.99 | -$3,976,462.87 | 232.22K |
Scheduled
|
Mar 7 - Mar 25
| ||
Form 4
| +4.79% | 3.1K |
$86.42 | -$212,852.46 | 67.67K |
Jan 21
| |||
Form 4
| +6,056.34% | 63.53K |
$101.84 | -$5,159,825.44 | 64.58K |
Jan 4 - Jan 5
| |||
Form 4
| -0.58% | -1.05K |
$62.98 | -$806,393.00 | 179.44K |
Scheduled
|
Aug 25 - Dec 28
| ||
Form 4
| +142.19% | 4.85K |
$102.50 | -$395,445.00 | 8.26K |
Jul 28
| |||
Form 4
| -37.41% | -102.92K |
$90.01 | -$9,263,846.96 | 172.23K |
Scheduled
|
May 14
| ||
Form 4
| +0.48% | 1.31K |
$87.17 | -$91,092.65 | 277.51K |
Feb 1 - Feb 17
| |||
Form 4
| +1.13% | 3.09K |
$77.43 | -$190,632.66 | 276.2K |
Jan 19 - Jan 21
| |||
Form 4
| +16,123.16% | 169.13K |
$73.28 | -$9,870,669.44 | 170.18K |
Jan 4 - Jan 5
| |||
Form 4
| -22.32% | -29.58K |
$75.76 | -$2,240,701.98 | 102.92K |
Scheduled
|
Aug 24
| ||
Form 4
| -44.21% | -104.99K |
$38.00 | -$3,989,772.00 | 132.5K |
Scheduled
|
May 5
| ||
Form 4
|
—
|
0
|
—
|
—
| 237.5K |
Feb 26
| |||
Form 4
| +3.65% | 8.36K |
$36.06 | -$239,762.94 | 237.45K |
Feb 14 - Feb 19
| |||
Form 4
| +1.37% | 3.09K |
$38.25 | -$94,133.25 | 229.14K |
Jan 21
| |||
Form 4
| +62.26% | 86.73K |
$36.10 | -$2,502,488.10 | 226.04K |
Jan 3 - Jan 5
| |||
Form 4
| -12.55% | -20.00K |
$28.01 | -$560,100.00 | 139.31K |
Scheduled
|
Oct 15
| ||
Form 4
| -0.85% | -1.36K |
$28.00 | -$38,052.00 | 159.31K |
Scheduled
|
Aug 30
| ||
Form 4
| -20.46% | -41.33K |
$22.45 | -$1,485,484.17 | 160.67K |
Scheduled
|
Aug 21 - Aug 22
| ||
Form 4
| +9.47% | 17.27K |
$26.84 | -$368,593.72 | 199.63K |
Mar 23
| |||
Form 4
| +28.38% | 40.31K |
$21.54 | -$690,658.56 | 182.36K |
Feb 20
| |||
Form 4
| +34.30% | 36.28K |
$20.39 | -$599,853.41 | 142.05K |
Jan 4 - Jan 5
| |||
Form 4
| +11.77% | 11.14K |
$17.67 | -$156,556.20 | 105.77K |
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
| +23.02% | 17.27K |
$13.86 | -$190,339.38 | 92.26K |
Mar 23
| |||
Form 4
| +16.93% | 10.86K |
$11.73 | -$107,212.20 | 75K |
Jun 23
| |||
Form 4
| +36.69% | 16.83K |
$14.56 | -$206,271.52 | 62.71K |
Mar 23
| |||
Form 4
| +32.29% | 11.36K |
$17.44 | -$150,733.92 | 46.53K |
Jun 23
| |||
Form 4
| +172.78% | 21.36K |
$16.32 | -$157,341.12 | 33.72K |
Mar 23
| |||
Form 4
|
∞
| 11.2K |
$34.27 | -$301,541.73 | 11.2K |
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
| No matching records found | |||||||||
Reneo Pharmaceuticals, Inc. (RPHM) Snapshot price: $1.43
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sagimet Biosciences Inc. (SGMT) Snapshot price: $2.65
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||